77% reduction in rate of progression - what is the 'average' time for progression from intermediate to late stage ? i.e. what is the 'average' time delay from intermediate to late stage for the 'average' patient receiving 2RT treatments ? & I guess also how many treatments at what cost ?
Lots of details to come out but their will be plenty of people willing to play the % game & try to delay AMD onset with 2RT treatments.
Pay per treatment. I was hoping this would be a revenue model as just selling the 2RT lasers would be a poor outcome.
.
- Forums
- ASX - By Stock
- Ann: ELX LEAD Clinical trial results
77% reduction in rate of progression - what is the 'average'...
Featured News
Add EYE (ASX) to my watchlist
(20min delay)
|
|||||
Last
16.0¢ |
Change
0.015(10.3%) |
Mkt cap ! $36.64M |
Open | High | Low | Value | Volume |
14.5¢ | 16.0¢ | 14.5¢ | $38.73K | 257.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 84655 | 15.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.0¢ | 271846 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 84655 | 0.150 |
10 | 625724 | 0.145 |
11 | 450030 | 0.140 |
4 | 44241 | 0.135 |
6 | 75850 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.160 | 271846 | 5 |
0.165 | 100000 | 1 |
0.170 | 100000 | 1 |
0.175 | 100000 | 1 |
0.185 | 20000 | 1 |
Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |
The Watchlist
3DA
AMAERO INTERNATIONAL LTD
Hank Holland, Executive Chairman and CEO
Hank Holland
Executive Chairman and CEO
Previous Video
Next Video
SPONSORED BY The Market Online